Lyra Therapeutics, Inc. today announced the closing of its previously announced private placement of common stock, pre-funded warrants to purchase common stock and purchase warrants to purchase common stock, resulting in gross proceeds of approximately $50.0 million.
June 1, 2023
· 7 min read